ClearAlpha Technologies LP Acquires 12,612 Shares of Amedisys, Inc. (NASDAQ:AMED)

ClearAlpha Technologies LP increased its holdings in Amedisys, Inc. (NASDAQ:AMED) by 19.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,861 shares of the health services provider’s stock after purchasing an additional 12,612 shares during the period. Amedisys makes up 2.1% of ClearAlpha Technologies LP’s portfolio, making the stock its 10th biggest position. ClearAlpha Technologies LP owned about 0.24% of Amedisys worth $7,514,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. SG Americas Securities LLC raised its holdings in shares of Amedisys by 413.4% in the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after buying an additional 158,398 shares in the last quarter. Verition Fund Management LLC lifted its holdings in shares of Amedisys by 608.1% during the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock valued at $11,077,000 after acquiring an additional 98,565 shares during the period. Westchester Capital Management LLC boosted its stake in shares of Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after purchasing an additional 97,476 shares in the last quarter. Highbridge Capital Management LLC boosted its stake in shares of Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after purchasing an additional 83,200 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Amedisys by 226.1% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 88,712 shares of the health services provider’s stock worth $8,562,000 after purchasing an additional 61,512 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Trading Up 0.2 %

Shares of AMED stock opened at $91.41 on Monday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $2.99 billion, a P/E ratio of 36.27, a P/E/G ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a 12-month low of $88.81 and a 12-month high of $98.95. The firm has a 50-day moving average price of $94.74 and a 200 day moving average price of $95.62.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the firm earned $0.98 earnings per share. The firm’s revenue was up 5.7% compared to the same quarter last year. Research analysts forecast that Amedisys, Inc. will post 4.55 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.